Song Y-Q, Zhang H-L, Huang H-Q, Zhang Q-Y, Jing H-M, Wang C, Wu C, Li D-H, Dai Y, Humphrey K, Zhu J. Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma. Haematologica 2024;109(4):1269-1273; https://doi.org/10.3324/haematol.2023.283802.